Articles

Poll

Podcasts

Slideshows

Videos

Norouzi reflects on significant advances in glomerular disease from Q1 and looks ahead to what the rest of 2025 may have to offer.

What’s New and What’s Next in Glomerular Disease Care, with Sayna Norouzi, MD

Prophylactic treatment with IV magnesium led to a lower risk of cisplatin-associated AKI in patients with cancer undergoing cisplatin chemotherapy.

Prophylactic IV Magnesium Linked to Lower Cisplatin-Associated AKI Risk

Several mobile apps effectively improved medication adherence in patients with CKD, posing important implications for their impact on clinical outcomes.

Mobile Apps Show Promise for Improving CKD Medication Adherence

Kraus explains current unmet needs in IgA nephropathy and what sibeprenlimab may offer based on the phase 3 VISIONARY study.

Sibeprenlimab’s Potential in IgA Nephropathy, with John Kraus, MD, PhD

Tumlin reviews findings from a posthoc analysis of DUPLEX demonstrating sparsentan’s impact on partial remission, complete remission, and kidney failure.

Sparsentan and Progression to Kidney Failure in FSGS, with James Tumlin, MD

Black patients disproportionately started dialysis at low-quality facilities and were less likely to have nephrologists with high-quality primary facilities.

Study Suggests Racial Disparities in Access to High-Quality Dialysis Facilities

Lafayette reflects on recent therapeutic advances in IgA nephropathy and looks ahead to other renal pipeline developments he’s looking forward to in 2025.

Progress in IgAN and Future Innovations in Nephrology, with Richard Lafayette, MD

An audio recap of the top 5 stories in healthcare news from the week of 03/31-04/06.



HCPLive 5 Stories in Under 5: Week of 04/06

Lafayette describes ongoing unmet needs in IgAN care and how the growing understanding of disease pathogenesis has informed drug development.

Understanding Atrasentan (Vanrafia) for IgA Nephropathy, with Richard Lafayette, MD

Most patients preferred OLC over their previous phosphate binder, and pill number and size were identified as barriers to phosphate binder adherence.

Oxylanthanum Carbonate May Offer Desirable Alternative to Current Phosphate Binders

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.